EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Characterization of Sulfonamide‐Schiff Bases, and Investigation of Cytotoxic, Antioxidant, HDAC, and Apoptotic Activities in Human Colon Cancer Cells (DLD‐1 and HT‐29)

Seda Mesci iD, Berna Kocaman iD, Aliye Gediz Erturk iD, Emine Bagdatli iD, Burak Yazgan iD, Tuba Yildirim iD

Archiv der Pharmazie · 2026-04 · 359 (4)

DOI: 10.1002/ardp.70235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 10.04.2026. Verfasst von Seda Mesci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Project Coordination and Guidance Office, Rectorate, Hitit University, Çorum, Turkey. Hauptthemen laut MEDLINE: Apoptosis, Antioxidants, Sulfonamides, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hitit Üniversitesi, Amasya Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Comprehending the intricate mechanisms of apoptosis and its interaction with cytotoxic, antioxidant, and HDAC activities is imperative for devising effective cancer therapies. Sulfonamides and Schiff bases are compounds of pharmacological importance with known anticancer activity. Our study aimed to investigate the cytotoxic, antioxidant, HDAC, and apoptotic activities of new sulfonamide‐Schiff bases in human colon cancer cells (DLD‐1 and HT‐29). New sulfonamide‐derived Schiff base compounds ( 3a – d ) were synthesized from the condensation of sulfamethoxypyridazine ( 1 ) and various aromatic aldehydes, and were characterized by FTIR, NMR ( 1 H and 13 C/APT), UV‐Vis., and mass spectroscopy. Sulfonamide‐derived Schiff bases 3a–d and compound 1 exhibited significant anticancer activity against colorectal cancer cell lines (DLD‐1, HT‐29). In the MTT assay, 3c was most active in DLD‐1 (viability: 37.7%, IC₅₀ = 3.94 µM) and 3b in HT‐29 (viability: 46.6%, IC₅₀ = 3.26 µM). In the WST‐8 assay, 3c was strongest in DLD‐1 (viability: 45.9%, IC₅₀ = 17.95 µM). None of the compounds showed toxicity in normal colon cells (CCD‐18Co). qRT‐PCR revealed upregulation of apoptotic (BAX, p53, Caspase‐3/8/9) and antioxidant (SOD‐1/2, CAT, GSS) genes, notably by 3a in DLD‐1 and 3d in HT‐29, while 3c reduced BCL‐2 in HT‐29 cells. ELISA confirmed strong antioxidant induction ( 3a : 70% in DLD‐1) and HDAC inhibition ( 3d : 69% in HT‐29). Western blot showed 3a increased p38/MAPK expression sevenfold in DLD‐1 and fourfold in HT‐29, while decreasing ERK1. Overall, 3c and 3d emerged as the most promising candidates, combining cytotoxic, antioxidant, HDAC inhibitory, and apoptotic effects, and may act as selective therapeutic agents by targeting the p38/MAPK–ERK1 pathway in colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisAntioxidantsSulfonamidesAntineoplastic AgentsColonic NeoplasmsHistone Deacetylase InhibitorsHumansSchiff BasesStructure-Activity RelationshipMolecular StructureHT29 CellsHistone DeacetylasesDose-Response Relationship, DrugDrug Screening Assays, AntitumorCell SurvivalCell Proliferation

Stichwörter der Autor:innen

HDACSchiff baseantioxidantapoptoticcolon cancercytotoxicsulfonamide

Substanzen

AntioxidantsSchiff BasesSulfonamidesAntineoplastic AgentsHistone Deacetylase InhibitorsHistone Deacetylases

Autor:innen und Institutionen

  • Project Coordination and Guidance Office, Rectorate, Hitit University, Çorum, Turkey.
  • Department of Biotechnology, Institute of Science, Amasya University, Amasya, Turkey.
  • Department of Chemistry, Faculty of Science and Arts, Ordu University, Ordu, Turkey.
  • Department of Medical Services and Techniques, Sabuncuoğlu Serefeddin Health Services Vocational School, Amasya University, Amasya, Turkey.
  • Department of Biology, Faculty of Art and Science, Amasya University, Amasya, Turkey.

ORCID-Profile: Seda Mesci, Berna Kocaman, Aliye Gediz Erturk, Emine Bagdatli, Burak Yazgan, Tuba Yildirim

Förderung

  • Hitit Üniversitesi
  • Amasya Üniversitesi

Zitieren

APA

Mesci, S., Kocaman, B., Erturk, A. G., Bagdatli, E., Yazgan, B., & Yildirim, T. (2026). Synthesis and Characterization of Sulfonamide‐Schiff Bases, and Investigation of Cytotoxic, Antioxidant, HDAC, and Apoptotic Activities in Human Colon Cancer Cells (DLD‐1 and HT‐29). Archiv der Pharmazie, 359(4). https://doi.org/10.1002/ardp.70235

Vancouver

Mesci S, Kocaman B, Erturk AG, Bagdatli E, Yazgan B, Yildirim T. Synthesis and Characterization of Sulfonamide‐Schiff Bases, and Investigation of Cytotoxic, Antioxidant, HDAC, and Apoptotic Activities in Human Colon Cancer Cells (DLD‐1 and HT‐29). Archiv der Pharmazie. 2026;359(4). doi:10.1002/ardp.70235

BibTeX
@article{Mesci2026,
  author = {Mesci, Seda and Kocaman, Berna and Erturk, Aliye Gediz and Bagdatli, Emine and Yazgan, Burak and Yildirim, Tuba},
  title = {Synthesis and Characterization of Sulfonamide‐Schiff Bases, and Investigation of Cytotoxic, Antioxidant, HDAC, and Apoptotic Activities in Human Colon Cancer Cells (DLD‐1 and HT‐29)},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {4},
  doi = {10.1002/ardp.70235}
}
Kostenlos starten →